Neurocrine Biosciences, Inc. (NBIX): Price and Financial Metrics
NBIX Price/Volume Stats
| Current price | $124.39 | 52-week high | $157.98 |
| Prev. close | $125.01 | 52-week low | $84.23 |
| Day low | $122.66 | Volume | 775,100 |
| Day high | $125.54 | Avg. volume | 1,406,121 |
| 50-day MA | $112.63 | Dividend yield | N/A |
| 200-day MA | $121.44 | Market Cap | 12.31B |
NBIX Stock Price Chart Interactive Chart >
Neurocrine Biosciences, Inc. (NBIX) Company Bio
Neurocrine Biosciences discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company was founded in 1992 and is based in San Diego, California.
NBIX Price Returns
| 1-mo | 2.78% |
| 3-mo | 11.56% |
| 6-mo | -9.00% |
| 1-year | -8.17% |
| 3-year | 39.87% |
| 5-year | 4.63% |
| YTD | -8.87% |
| 2024 | 3.60% |
| 2023 | 10.31% |
| 2022 | 40.24% |
| 2021 | -11.14% |
| 2020 | -10.83% |
Continue Researching NBIX
Want to do more research on Neurocrine Biosciences Inc's stock and its price? Try the links below:Neurocrine Biosciences Inc (NBIX) Stock Price | Nasdaq
Neurocrine Biosciences Inc (NBIX) Stock Quote, History and News - Yahoo Finance
Neurocrine Biosciences Inc (NBIX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...